Janssen Search
Search results
Johnson & Johnson Completes Acquisition of Ambrx
Mar 07, 2024 United Stats Acquisition strengthens Johnson & Johnson’s commitment to innovation in prostate cancer and deepens pipeline of next-generation antibody drug conjugates and targeted oncologic therapeutics NEW BRUNSWICK, NJ (March 7, 2024) ...
Meet Our Immunology Affiliates
Our Affiliates in Immunology Janssen Research & Development partners closely with other organizations within the Janssen Pharmaceutical Companies of Johnson & Johnson to ensure that the scientific advances from our immunology pioneers reach the ...
World Without Disease Accelerator
World Without Disease Accelerator World Without Disease Accelerator About World Without Disease Accelerator Data Sciences & Prevention Biomarkers Immunosciences Microbiome Solutions Sensors & Wearables Behavioral Neurobiology Lung Cancer Type 1 ...
Accelerating Hope for Children
Accelerating Hope for Children For nearly 20 years, Janssen, the pharmaceutical companies of Johnson & Johnson (J&J), have been working to bring hope to the millions of children with serious diseases worldwide. With a science- and evidence-based ...
Neuroscience Product Commercialization
Commercialization "We have delivered more than 20 medications and innovations for nervous system disorders to patients around the world, and our work does not end there. Extending and enhancing the quality of people’s lives remains our greatest ...
Eric Schaeffer, Ph.D.
ERIC SCHAEFFER, PH.D. SENIOR DIRECTOR NEUROSCIENCE INNOVATION BOSTON INNOVATION CENTER Eric Schaeffer, Ph.D. received his degree from the Albert Einstein College of Medicine in New York City, and went on to do post-doctoral fellowships at the ...
Global Reach
Article Type: Infectious Diseases & Vaccines Global Reach We seek opportunities to combine our scientific capabilities with world-class innovation from government, industry and academia to speed up the development of solutions that will combat the ...
World Neuroscience Innovation Forum
Janssen is a sponsor of the World Neuroscience Innovation Forum on March 27, 2017, in London. The conference will cover the latest in neuroscience research and innovation. The goal of the London Forum is to spark new insights, therapeutic paths and ...
Alexander Grunewald
Alexander Grunewald enables Janssen Healthcare Innovation’s (JHI) growth by identifying, valuing, and championing new business opportunities. Alexander builds strong external relationships with the healthcare innovation and investment communities in areas ...
Fighting Infectious Disease in China
Article Type: Infectious Diseases & Vaccines Tackling Infectious Diseases in China For several years Janssen has partnered with Tsinghua University in Beijing, China to host a Public Health Day that featured academia, leading government officials and ...